1Barrass B JR, Thurairaja R, Persad RA.More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer. BJU Int,2004,93:1175 -1176.
2Diamond TH, Higano CS, Smith MR, et al. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy:recommendations for diagnosis and therapies. Cancer,2004,100: 892-899.
3Higano CS. Understanding treatments for bone and bone metastases in patients with prostate cancer: a practical review and guide for the cli- nician. Urol Clin North Am,2004,31:331-352.
4Higano CS. Bone loss and the evolving role of bisphosphonate therapy in prostate cancer. Urol Oncol,2003,21:392-398.
5Roodman GD. Mechanism of bone metastasis. N Engl J Med, 2004,15:1655-1664.
6Gilbert SM, Olsson CA, Benson MC, et al. The role of intravenous zoledronic acid in the treatment of high-risk prostate cancer. Cur Opin Urol,2003 ,13 :133-135.
7Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res,2002,62:6538-6544.
8Koupparis A, Ramsden A, Persad C. Cognitive effects of hormonal treatment for prostate cancer. BJU Int,2004,93:915-916.
9Stephen B. In: Physicians Desk Reference. Vol 51. Washington: Department of health and human services, 1997: 2498.
10Fau D, Eugene A, et al. Toxicity of the antiandrogen flutamide in isolated rat hepatoeytes. J Pharmacol Exp Ther, 1994 Jun, 269 (3):954.
7Michael Gnant, Brigitte Mlineritsch, Walter Schippinger, et al. Endocrine therapy plus zoledronic acid in premenopausal breast cancer [J]. N Engl J Med,2009,360(7) :679-691.
8Forward DP, Cheung KL, Jackson L, et al. Clinical and endocrine data for goserelin plus anastrozole as secondline endocrine therapy for premenopausal advanced breast cancer[ J ]. Br J Cancer,2004,90 (3) :590- 594.
10Brufsky A, Harker WG, Beck JT, et al. Zoledronic acid inhibits adjuvant letrozolc induced bone loss in postmenopausal women with early breast cancer[ J]. J Clin Oncol,2007,25 (7) :829-836.
